Skip to search formSkip to main contentSkip to account menu

Nervous system involvement after infection with COVID-19 and other coronaviruses

View on Elsevier (opens in a new tab)

Vicarious traumatization in the general public, members, and non-members of medical teams aiding in COVID-19 control

View on Elsevier (opens in a new tab)

Immune Activation During Pregnancy in Mice Leads to Dopaminergic Hyperfunction and Cognitive Impairment in the Offspring: A Neurodevelopmental Animal Model of Schizophrenia

View on Elsevier (opens in a new tab)

Alterations of serum levels of brain-derived neurotrophic factor (BDNF) in depressed patients with or without antidepressants

View on Elsevier (opens in a new tab)

Knowledge and attitudes of medical staff in Chinese psychiatric hospitals regarding COVID-19

View on Elsevier (opens in a new tab)

Ethnic difference of the BDNF 196G/A (val66met) polymorphism frequencies: The possibility to explain ethnic mental traits

It is indicated that both BDNF and serotonin transporter have ethnic differences in frequencies of the polymorphisms, suggesting that BDNFand serotonin transporter may act in harmony to produce ethnic traits.
View on Wiley (opens in a new tab)

R-ketamine: a rapid-onset and sustained antidepressant without psychotomimetic side effects

In the social defeat stress and learned helplessness models of depression, R-ketamine showed a greater potency and longer-lasting antidepressant effect than S-ketamines (esketamine), and findings suggest that, unlike S- ketamine, R -ketamine can elicit a sustained antidepressant effect, mediated by increased BDNF–TrkB signaling and synaptogenesis in the PFC, DG and CA3.
View on Nature (opens in a new tab)

Increased Levels of Glutamate in Brains from Patients with Mood Disorders

View on Elsevier (opens in a new tab)

Brain‐derived neurotrophic factor as a biomarker for mood disorders: An historical overview and future directions

  • K. Hashimoto
  • Psychology, Biology
    Psychiatry and Clinical Neurosciences
  • 1 August 2010
An historical overview of the role played by BDNF in the pathophysiology of mood disorders and in the mechanism of action of therapeutic agents is provided and particular focus will be given to the potential use of BDNF as a biomarker for mood disorders.
View on Wiley (opens in a new tab)

Current status of potential therapeutic candidates for the COVID-19 crisis

View on Elsevier (opens in a new tab)
...
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)